Removing Regulatory Hurdles for Continuous Pharmaceutical Manufacturing
ISPE
JULY 5, 2023
13 An FDA-authored paper indicating support for the implementation of CM using science- and risk-based approaches followed soon thereafter. 13 An FDA-authored paper indicating support for the implementation of CM using science- and risk-based approaches followed soon thereafter.
Let's personalize your content